LEIDEN JEFFREY M (Executive Chairman) received a stock award from VERTEX PHARMACEUTICALS INC / MA
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/14/2025ACC: 0000875320-25-000071
DirectorOfficer· Executive Chairman
Since Feb 2026
+4.68K
Net shares
Net buyer
$1.14M
Total sold
0
Open market trades
0B · 0S
2
Total transactions
7.21K acquired · 2.52K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+7.21K
Price / share
—
Trade value
—
% of position
28.4%
2/12/2025
25.41K→32.62K
Common Stock
Direct
Shares
−2.52K
Price / share
$450.83
Trade value
$1.14M
% of position
7.7%
2/13/2025
32.62K→30.09K
Total
Net shares
+4.68K
Net value
-$1.14M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/12/2025 | A · Award | +7.21K | — | — | 28.4% | 25.41K | 32.62K |
| Common Stock Direct | 2/13/2025 | F · Tax Withholding | −2.52K | $450.83 | $1.14M | 7.7% | 32.62K | 30.09K |
| Total | +4.68K | -$1.14M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned440.00
Total
440.00 indirect440.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 440.00 | Indirect |
| Total | 440.00 | 440.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported